Two novel loci underlie natural differences in Caenorhabditis elegans abamectin responses
Authors:
- Kathryn S. EvansKEKathryn S. Evans
- Janneke WitJWJanneke Wit
- Lewis StevensLSLewis Stevens
- Briana RodriguezBRBriana Rodriguez
- Grace ParkGPGrace Park
- Mostafa ZamanianMZMostafa Zamanian
- Ellen ChaoECEllen Chao
- Katherine IntrocasoKIKatherine Introcaso
- Robyn E. TannyRTRobyn E. Tanny
- Erik C. AndersenEAErik C. Andersen
Open Access
- 15 March 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 17 (3) , e1009297
Abstract
Parasitic nematodes cause a massive worldwide burden on human health along with a loss of livestock and agriculture productivity. Anthelmintics have been widely successful in treating parasitic nematodes. However, resistance is increasing, and little is known about the molecular and genetic causes of resistance for most of these drugs. The free-living roundworm Caenorhabditis elegans provides a tractable model to identify genes that underlie resistance. Unlike parasitic nematodes, C. elegans is easy to maintain in the laboratory, has a complete and well annotated genome, and has many genetic tools. Using a combination of wild isolates and a panel of recombinant inbred lines constructed from crosses of two genetically and phenotypically divergent strains, we identified three genomic regions on chromosome V that underlie natural differences in response to the macrocyclic lactone (ML) abamectin. One locus was identified previously and encodes an alpha subunit of a glutamate-gated chloride channel (glc-1). Here, we validate and narrow two novel loci using near-isogenic lines. Additionally, we generate a list of prioritized candidate genes identified in C. elegans and in the parasite Haemonchus contortus by comparison of ML resistance loci. These genes could represent previously unidentified resistance genes shared across nematode species and should be evaluated in the future. Our work highlights the advantages of using C. elegans as a model to better understand ML resistance in parasitic nematodes.Keywords
All Related Versions
Funding Information
- National Institute of Allergy and Infectious Diseases (AI121836)
- National Institute of Allergy and Infectious Diseases (AI153088)
- Simons Foundation (SFARI 597491-RWC)
- National Science Foundation (1764421)
- National Institute of General Medical Sciences (T32 GM008061)
- Deutsche Forschungsgemeinschaft (HA 8449/1-1)
This publication has 73 references indexed in Scilit:
- Haemonchus contortusas a paradigm and model to study anthelmintic drug resistanceParasitology, 2013
- Caenorhabditis elegans as a Model in Developmental Toxicology2012
- A Research Agenda for Helminth Diseases of Humans: The Problem of HelminthiasesPLOS Neglected Tropical Diseases, 2012
- Natural Variation in a Chloride Channel Subunit Confers Avermectin Resistance in C. elegansScience, 2012
- A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing dataBioinformatics, 2011
- Selection at Linked Sites Shapes Heritable Phenotypic Variation in C. elegansScience, 2010
- Recombinational Landscape and Population Genomics of Caenorhabditis elegansPLOS Genetics, 2009
- PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage AnalysesThe American Journal of Human Genetics, 2007
- New Genes Tied to Endocrine, Metabolic, and Dietary Regulation of Lifespan from a Caenorhabditis elegans Genomic RNAi ScreenPLOS Genetics, 2005
- Mode of action of benzimidazolesParasitology Today, 1990